Palisade Bio Inc.
PALI | NASDAQ
$1.61
-$0.08 (-4.73%)
Sep 22, 2026, 12:06 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 250K | 250K | 250K | 250K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 103K | 103K |
Gross Profit | 500K | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -1K | -1K | 250K | 250K | 250K | 250K | n/a | n/a | n/a | n/a | n/a | n/a | -103K | -100.5K |
Operating Income | -35.35M | -26.49M | -18.06M | -11.46M | -12.13M | -13.5M | -14.86M | -14.63M | -14.82M | -14.21M | -13.07M | -13.76M | -14.4M | -14.36M | -15.72M | -15.9M | -14.5M | -43.79M | -41.86M | -41.07M | -39.87M | -8.86M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -31.94M | -24.15M | -16.78M | -11.23M | -11.85M | -13.14M | -14.44M | -14.07M | -14.17M | -13.49M | -12.3M | -13.05M | -13.44M | -12.4M | -14.26M | -9.47M | 2.61M | -26.79M | -26.62M | -31.93M | -41.86M | -12.07M |
Net Income | -31.94M | -24.15M | -16.78M | -11.23M | -11.85M | -13.14M | -14.44M | -14.07M | -14.17M | -13.49M | -12.3M | -13.05M | -13.44M | -12.4M | -14.26M | -9.47M | 2.61M | -26.79M | -26.62M | -31.93M | -41.86M | -11.97M |
Selling & General & Admin | 14.49M | 10.86M | 7.86M | 5.35M | 5.28M | 5.7M | 5.8M | 6.06M | 6.27M | 6.12M | 6.2M | 6.15M | 6.55M | 7.37M | 8.76M | 10.49M | 10.8M | 10.98M | 9.31M | 8.54M | 7.45M | 6.21M |
Research & Development | 21.36M | 15.64M | 10.19M | 6.1M | 6.85M | 7.8M | 9.06M | 8.35M | 8.32M | 7.87M | 6.89M | 7.87M | 7.69M | 6.83M | 6.55M | 5M | 3.7M | 2.7M | 2.43M | 2.42M | 2.2M | 2.54M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 225K | 225K | 225K | 225K | n/a | 410K | 410K | 410K | 410K | n/a | 30.12M | 30.12M | 30.12M | 30.12M | 1K |
Operating Expenses | 35.85M | 26.49M | 18.06M | 11.46M | 12.13M | 13.5M | 14.86M | 14.63M | 14.82M | 14.21M | 13.32M | 14.01M | 14.65M | 14.61M | 15.72M | 15.9M | 14.5M | 43.79M | 41.86M | 41.07M | 39.77M | 8.75M |
Interest Expense | 6K | 8K | 10K | 11K | 12K | 12K | 12K | 13K | 15K | 16K | 15K | 14K | 10K | 12K | 13K | 15K | 37K | 687K | 2.4M | 3.43M | 3.43M | 2.79M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 35.85M | 26.49M | 18.06M | 11.46M | 12.13M | 13.5M | 14.86M | 14.63M | 14.82M | 14.21M | 13.32M | 14.01M | 14.65M | 14.61M | 15.72M | 15.9M | 14.5M | 43.79M | 41.86M | 41.07M | 39.87M | 8.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.63K |
Shares Outstanding (Basic) | 211.38M | 209.66M | 55.67M | 7.47M | 4.8M | 4.8M | 5.82M | 5.82M | 5.82M | 768.14K | 5.82M | 6.26M | 6.4M | 4.32M | 1.8M | 64.95K | 405.9K | 324.45K | 270.66K | 16.13K | 11.78K | 832.35K |
Shares Outstanding (Diluted) | 211.38M | 209.66M | 55.67M | 7.47M | 4.8M | 4.8M | 8.54M | 5.82M | 5.82M | 12.63M | 9.27M | 489.62K | 427.86K | 287.7K | 1.8M | 64.95K | 405.9K | 324.48K | 270.66K | 242.13K | 11.98K | 237.39K |
EPS (Basic) | -0.53 | -1.06 | -1.48 | -1.99 | -3.93 | -6.67 | -10.80 | -10.74 | -15.80 | -20.41 | -23.95 | -24.93 | -79.05 | -157.67 | -343.94 | -338.49 | 38.01 | -2.57K | -2.38K | -2.39K | -2.7K | -514.65 |
EPS (Diluted) | -0.53 | -1.06 | -1.48 | -1.81 | -3.75 | -6.49 | -10.62 | -10.55 | -15.61 | -20.22 | -23.76 | -24.93 | -79.05 | -73.87 | -79.68 | -74.23 | 20.67 | -3.05K | -3.05K | -3.08K | -3.12K | -50.42 |
EBITDA | -33.22M | -25.43M | -18.05M | -11.21M | -11.83M | -13.13M | -14.42M | -14.01M | -14.12M | -13.43M | -12.24M | -13.03M | -13.38M | -12.29M | -14.15M | -9.31M | 2.87M | -25.93M | -24.04M | -29.21M | -39.17M | -9.92M |
EBIT | -33.22M | -25.43M | -18.06M | -11.22M | -11.83M | -13.13M | -14.43M | -14.01M | -14.12M | -13.43M | -12.25M | -13.04M | -13.43M | -12.38M | -14.25M | -9.45M | 2.65M | -26.1M | -24.22M | -29.35M | -39.27M | -10.02M |
Depreciation & Amortization | 1K | 2K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 4K | 4K | 6K | 51K | 98K | 98K | 140K | 225K | 177K | 177K | 134K | 106K | 105.5K |
Add to Watchlist
Select watchlists to add or remove PALI